Piper Sandler Cuts LENZ Therapeutics Price Target to $5 From $7
Piper Sandler lowered its price target for LENZ Therapeutics to $5 per share from $7.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.